Partner, Venture Investments
Clinical trial shows effectiveness of AI-driven app Sweetch is a start-up with a mobile health app that aims to use AI to help users prevent diabetes — or improve outcomes for users who have diabetes. The app personalizes recommendations for each user, offering them the tailored support and encouragement they need to make long-term behavior changes. In 2016, Sweetch raised $3.5 million, led by global conglomerate Philips and equity crowdfunding platform OurCrowd. A clinical trial conducted at Johns Hopkins University found that Sweetch was highly effective at modifying participant behavior. On average, participants lost weight, reduced their waist circumference and had a clinically meaningful reduction in their A1C levels.
You are about to visit a Philips global content page
ContinueSvetainė skirta tik asmenims, naudojantiems medicinos priemones profesinėje veikloje, įskaitant sveikatos priežiūros specialistams, profesinę veiklą vykdantiems asmenims, atstovaujantiems sveikatos priežiūros įstaigą ar medicinos priemonėmis prekiaujančią organizaciją.
Ar esate asmuo, atitinkantis aukščiau nurodytus kriterijus?